Pharmaceutical Delivery Systems

Jabil and Pii Join Forces to Serve Pharmaceutical Market

On February, 3, 2025, Jabil acquired Pii Pharmaceutics International, a Contract Development and Manufacturing Organization (CDMO) that specializes in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing.

Expanded Solutions for End-to-End Services

This acquisition will significantly enhance Jabil’s existing Pharmaceutical Solutions offering which includes the development and commercial production of auto-injectors, pen injectors, inhalers, and on-body pumps. With the addition of Pii’s leading scientific insights, depth of product knowledge, and capabilities across aseptic filling, lyophilization, and oral solid dose manufacturing, Jabil will have a comprehensive portfolio of services to meet the clinical and commercial drug manufacturing demands of our healthcare customers.

Benefits to Customers

With our shared commitment to creating the best possible solutions for patients around the world, we believe the addition of Pii’s capabilities, supported by their over 300 team members, is a perfect fit for Jabil and our customers. The convergence of Jabil’s and Pii’s complementary capabilities will bolster our customer offering and extend our already vertically integrated manufacturing services. From design and development to aseptic filling and final test and pack, Jabil can be a single pair of safe hands for all of your pharmaceutical products.

Expanded Capabilities

Pii offers customized drug development solutions, specializing in analytical, development, and manufacturing services that complement Jabil’s robust portfolio of design and  manufacturing capabilities. 

• Formulation & Process Development
• Pre-filled Syringe
• Oral Drug Development
• Parenteral Drug Development
  • Aseptic Manufacturing
  • Lyophilized Drugs, Proteins & Biologics
  • Highly Potent Manufacturing
• Commercial Manufacturing
  • Serialization
  • Vaccine Fill-Finish Tech Transfer
• Clinical Trial Manufacturing